14-74763992-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019589.3(YLPM1):c.503C>T(p.Pro168Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,451,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019589.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YLPM1 | NM_019589.3 | c.503C>T | p.Pro168Leu | missense_variant | 1/21 | ENST00000325680.12 | NP_062535.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YLPM1 | ENST00000325680.12 | c.503C>T | p.Pro168Leu | missense_variant | 1/21 | 5 | NM_019589.3 | ENSP00000324463.7 | ||
YLPM1 | ENST00000552421.5 | c.503C>T | p.Pro168Leu | missense_variant | 1/20 | 5 | ENSP00000447921.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 143506Hom.: 0 Cov.: 22 FAILED QC
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1451868Hom.: 0 Cov.: 36 AF XY: 0.00000277 AC XY: 2AN XY: 721512
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000697 AC: 1AN: 143506Hom.: 0 Cov.: 22 AF XY: 0.0000144 AC XY: 1AN XY: 69314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.503C>T (p.P168L) alteration is located in exon 1 (coding exon 1) of the YLPM1 gene. This alteration results from a C to T substitution at nucleotide position 503, causing the proline (P) at amino acid position 168 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at